Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium

Kidney Int. 2002 Mar;61(3):804-8. doi: 10.1046/j.1523-1755.2002.00224.x.

Abstract

Background: Matrix metalloproteinases (MMPs) are synthesized in response to diverse stimuli including cytokines, growth factors, hormones, and oxidative stress.

Methods: Bovine aortic endothelial cells (BAEC) were stimulated with nitric oxide (NO) and MMP-13 expression and activity was assayed.

Results: NO transcriptionally regulated matrix metalloproteinase-13 (MMP-13) expression in BAEC, while the cGMP analog 8Br-cGMP mimicked the effect of NO. In addition NO also stimulated the proteolytic processing of MMP-13 from the pro-enzyme to the final active form in a dose dependent manner.

Conclusion: NO transcriptionally regulates MMP expression and activity in the vascular endothelium. This effect of NO may be of pathophysiological importance in the context of angiogenesis, inflammation or atherogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Collagenases / metabolism*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / enzymology*
  • Hydrazines / administration & dosage
  • Hydrazines / pharmacology
  • Matrix Metalloproteinase 13
  • Nitric Oxide / physiology*
  • Nitric Oxide Donors / administration & dosage
  • Nitric Oxide Donors / pharmacology
  • Nitrogen Oxides

Substances

  • Hydrazines
  • Nitric Oxide Donors
  • Nitrogen Oxides
  • Nitric Oxide
  • 1,1-diethyl-2-hydroxy-2-nitrosohydrazine
  • Collagenases
  • Matrix Metalloproteinase 13